3M sells Australian pharma operations
Australia's Ironbridge Capital and Archer Capital have bought the Australian pharmaceutical operations of American diversified manufacturer 3M, including its South African assets, for US$349m.
Australia's Ironbridge Capital and Archer Capital have bought the Australian pharmaceutical operations of American diversified manufacturer 3M, including its South African assets, for US$349m.
According to a joint statement issued by the companies Graceway Pharmaceuticals bought operations in the US, Canada and Latin America for $875m, and Swedish drugs group Meda AB will buy 3M's pharmaceutical business in Europe for $857m.